Skip to main content

Table 1 Demographic characteristics of transplant recipients

From: Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys

 

DD0 (N = 234)

DD1 (N = 83)

LD (N = 152)

P value DD0 v DD1

P value DD0 v LD

P value DD1 v LD

Recipient Characteristics

Recipient age at transplant, years mean ± SD (range)

58.5 ± 11

(22–79)

52.8 ± 13

(24–75)

46.6 ± 13

(17–74)

 < 0.001

 < 0.0001

0.001

Male N (%)

149 (63.7)

53 (63.9)

93 (68.4)

0.976

0.358

0.490

Race/Ethnicity N (%)

Caucasian

82 (35)

32 (39)

87 (57)

0.566

 < 0.0001

0.009

Black

42 (18)

11 (13)

7 (5)

0.324

0.0002

0.017

East Asian

55 (24)

14 (17)

25 (17)

0.208

0.094

0.893

South Asian

50 (21)

22 (27)

31 (20)

0.337

0.859

0.311

Hispanic

5 (2)

4 (3)

2 (1)

0.248

0.491

0.148

Dialysis duration (months)

70.3 ± 32

60 ± 26

22.1 ± 17

0.012

 < 0.0001

 < 0.0001

Peak PRA (%)

28 ± 33

42 ± 38

16 ± 27

0.004

0.002

 < 0.0001

Smoking N (%)

55 (23.5)

33 (39.8)

50 (36.8)

0.004

0.006

0.657

CVD N (%)

102 (43.6)

34 (40.9)

49 (36.0)

0.677

0.153

0.465

Cause of End Stage Kidney Disease N (%)

Diabetes

65 (28)

14 (17)

24 (16)

0.048

0.011

0.893

Hypertension

19 (8)

5 (6)

8 (5)

0.535

0.280

0.782

Glomerulonephritis

72 (31)

35 (42)

54 (35)

0.059

0.370

0.309

Polycystic kidney disease

18 (8)

10 (12)

23 (15)

0.229

0.019

0.484

Congenital

15 (6)

2 (3)

18 (12)

0.131

0.073

0.010

Interstitial nephritis

6 (2)

6 (7)

7 (4)

0.062

0.249

0.374

Others

39 (17)

11 (13)

18 (12)

0.463

0.201

0.745

Donor characteristics

Donor age, years

mean ± SD

49.5 ± 15

48.7 ± 13

42.8 ± 12

0.673

 < 0.0001

0.001

NDD/DCD N (%)

171(73)/ 63(27)

63(76)/ 20(24)

NA

0.659

NA

NA

SCD/ECD N (%)

138(59)/ 96(41)

55(66)/ 28(34)

NA

0.295

NA

NA

Terminal serum creatinine (umol/L)

mean ± SD

65 ± 22

68 ± 28

NA

0.611

NA

NA

Cold Ischemia Time (minutes)

mean ± SD

619 ± 240

622 ± 261

NA

0.23

NA

NA

  1. Two patients received two transplants; each was counted as a discrete transplant. CVD Cardiovascular disease, DCD Donation after cardiocirculatory death, ECD Expanded criteria donor, NDD Neurological determination of death, PRA Panel reactive antibody, SCD Standard criteria donor, umol/L micromole/litre. For DD0, DD1, LD definitions see text